Skip to NavigationSkip to content

Pharmafile - Sales and Marketing

Janssen's Erleada expanded in Europe to cover metastatic hormone-sensitive prostate cancer
Janssen’s Erleada has secured expanded authorisation from the European Commission, approving its label to include the treatment of metastatic...
FDA approves Teva's Ajovy autoinjector for treatment of migraine
Israeli pharma firm Teva has revealed that the FDA has chosen to award approval to its autoinjector device for the delivery of its Ajovy (...
NICE rejects Janssen's esketamine nasal spray Spravato for treatment-resistant depression
Janssen’s Spravato (esketamine) nasal spray, derived from the party drug ketamine, has been turned down by NICE for NHS use in England and Wales...
FDA approves MS drug for human trials
A drug that can make it easier to diagnose MS has been approved for its first human trials by the FDA.
>> More Sales and Marketing News Stories

Features

Realising the potential of greater collaboration for women living with cancer

Following the launch of a new global report, ‘Supporting Women With Cancer’, Lynn Taylor, Senior Vice President, Head of Healthcare Global...

>> More Features

Appointments

Ipsen appoints new Exec VP and Chief Medical Officer

Ipsen has named Dr Steven Hildemann as its new Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs and...

For more appointments click here

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches